cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Gossamer Bio Inc
6 own
10 watching
Current Price
$0.78
$0.06
(8.64%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
55.69M
52-Week High
52-Week High
9.55000
52-Week Low
52-Week Low
0.45300
Average Volume
Average Volume
1.49M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization55.69M
icon52-Week High9.55000
icon52-Week Low0.45300
iconAverage Volume1.49M
iconDividend Yield--
iconP/E Ratio--
What does the Gossamer Bio Inc do?
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. It is developing GB001, an oral antagonist of prostaglandin D2 receptor 2 that is in Phase IIb clinical trial for the treatment of moderate-to-severe eosinophilic asthma, as well as that has completed Phase I clinical trial for chronic rhinosinusitis with nasal polyps, without nasal polyps, and chronic spontaneous urticarial; GB002, a platelet-derived growth factor, receptor kinase inhibitor that is in Phase I clinical trial for the treatment of pulmonary arterial hypertension; GB004, an oral small molecule that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases; and GB1275, an oral small molecule for the treatment of oncology indications. It has license agreement with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was founded in 2015 and is headquartered in San Diego, California.
Read More
How much money does Gossamer Bio Inc make?
News & Events about Gossamer Bio Inc.
Ticker Report
7 months ago
Shares of Gossamer Bio, Inc. (NASDAQ:GOSS Get Rating) have received a consensus rating of Hold from the fourteen research firms that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six...
Zolmax
8 months ago
Gossamer Bio, Inc. (NASDAQ:GOSS Get Rating) CEO Faheem Hasnain bought 440,500 shares of the stock in a transaction that occurred on Wednesday, March 22nd. The shares were purchased at an average cost of $1.14 per share, with a total value of $502,170.00. Following the purchase, the chief executive ...
Ticker Report
8 months ago
Gossamer Bio, Inc. (NASDAQ:GOSS Get Rating) HC Wainwright issued their FY2027 earnings estimates for Gossamer Bio in a research note issued to investors on Tuesday, March 21st. HC Wainwright analyst P. Trucchio anticipates that the company will earn ($0.59) per share for the year. HC...
Zolmax
8 months ago
Gossamer Bio (NASDAQ:GOSS Get Rating) had its price objective cut by investment analysts at Barclays from $2.00 to $1.50 in a note issued to investors on Tuesday, The Fly reports. The firm presently has an equal weight rating on the stock. Barclayss target price points to a potential upside of 35.14...
Business Wire
8 months ago
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial results for the fourth quarter and year ended...
Frequently Asked Questions
Frequently Asked Questions
What is Gossamer Bio Inc share price today?
plus_minus_icon
Can Indians buy Gossamer Bio Inc shares?
plus_minus_icon
How can I buy Gossamer Bio Inc shares from India?
plus_minus_icon
Can Fractional shares of Gossamer Bio Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Gossamer Bio Inc stocks?
plus_minus_icon
What is today’s traded volume of Gossamer Bio Inc?
plus_minus_icon
What is today’s market capitalisation of Gossamer Bio Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Gossamer Bio Inc?
plus_minus_icon
What percentage is Gossamer Bio Inc down from its 52-Week High?
plus_minus_icon
What percentage is Gossamer Bio Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.78
$0.06
(8.64%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
KINNATE BIOPHARMA INC
KINNATE BIOPHARMA INC
$2.27
$0.00 (0.00 %)
Precision BioSciences Inc
Precision BioSciences Inc
$0.36
$-0.01 (-4.03 %)
ADC Therapeutics SA
ADC Therapeutics SA
$0.83
$0.06 (7.79 %)
Taysha Gene Therapies Inc
Taysha Gene Therapies Inc
$1.76
$-0.06 (-3.30 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
KINNATE BIOPHARMA INC
KINNATE BIOPHARMA INC
$2.27
$0.00 (0.00 %)
Precision BioSciences Inc
Precision BioSciences Inc
$0.36
$-0.01 (-4.03 %)
ADC Therapeutics SA
ADC Therapeutics SA
$0.83
$0.06 (7.79 %)
Taysha Gene Therapies Inc
Taysha Gene Therapies Inc
$1.76
$-0.06 (-3.30 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00